Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $615.0600 (0.5%) ($610.2270 - $619.5200) on Thu. Aug. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 47 | Latest Price | $615.0600(0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(45%) SPLV(39%) IVW(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.135% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $614.33(-0.12%) | Inflection Point | Yes | Resistance Level | $617.3 | 5 Day Moving Average | $607.35(1.27%) | 10 Day Moving Average | $613.28(0.29%) | 20 Day Moving Average | $617.3(-0.36%) | To recent high | -6.5% | To recent low | 13% | Market Cap | $65.214b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |